PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $65,000 | -72.5% | 33,571 | -57.7% | 0.01% | -68.8% |
Q1 2022 | $236,000 | +0.4% | 79,448 | +52.0% | 0.03% | +6.7% |
Q4 2021 | $235,000 | -39.1% | 52,256 | -34.2% | 0.03% | -23.1% |
Q3 2021 | $386,000 | +227.1% | 79,436 | +360.7% | 0.04% | +200.0% |
Q2 2021 | $118,000 | – | 17,244 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 3,387,172 | $6,537,000 | 1.72% |
Worth Venture Partners, LLC | 969,698 | $2,366,000 | 1.39% |
Omega Fund Management, LLC | 1,971,241 | $3,804,000 | 1.21% |
Telemetry Investments, L.L.C. | 495,000 | $955,000 | 1.13% |
CM Management, LLC | 350,000 | $676,000 | 0.72% |
Bruce & Co., Inc. | 1,557,312 | $3,005,000 | 0.71% |
Trellus Management Company, LLC | 295,000 | $569,000 | 0.69% |
Abingworth LLP | 1,041,131 | $1,999,000 | 0.64% |
1492 Capital Management LLC | 489,376 | $944,000 | 0.62% |
GENERAL AMERICAN INVESTORS CO INC | 1,752,470 | $3,382,000 | 0.34% |